Indeed, some of the earliest connections among the higher expression of proto-oncogenes (such as MYC), genetic rearrangements and their relation to cancer development were made in Burkitt lymphoma, chronic myeloid leukemia and mouse plasmacytomas. This evidence concerns the gene MYC and chronic myelogenous leukemia, BCR-ABL1 positive.